Risk management in cannabis businesses should include a comprehensive, sustainable strategy.
Cannabis industry professionals have the opportunity to not reinvent the wheel by learning from horticultural practices.
Schedule II classification may bring major obstacles for the current industry.
Cannabis can lead the way in research and development of sustainable, medical-grade, phytonutrient-dense crop production methodologies.
Good Chemistry’s STATS guide is meant as a tool for consumer education in identifying quality.
Doctors need more education on recommending cannabis and the legal ramifications.
State legal protections and medical research should spur insurance companies to tackle cannabis.
Developing SOPs for cultivation practices and sales protocols help companies stay compliant.
The stigma associated with cannabis and its federal illegality prevent the normalization of cannabis business.
States like New York, Massachusetts, Pennsylvania and Connecticut could quickly become hubs for the medical cannabis industry.